This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Kyowa Kirin Co., Ltd., Idemitsu Kosan., Ltd., National University Corporation Tokai National Higher Education and Research System. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023-2026
Title: Kei Yoshida: Innovator in Organic Electroluminescent Technology
Introduction
Kei Yoshida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of organic electroluminescent elements and compounds with anticancer activity. With a total of 3 patents to his name, his work continues to influence advancements in technology and medicine.
Latest Patents
Yoshida's latest patents include a compound and material for organic electroluminescent elements, as well as an organic electroluminescent element and electronic device. One of his notable inventions is a compound represented by specific formulae, which is utilized in organic electroluminescent devices. Additionally, he has developed a compound with anticancer activity, providing a pharmaceutically acceptable salt that demonstrates potential in cancer treatment.
Career Highlights
Throughout his career, Kei Yoshida has worked with esteemed companies such as Kyowa Kirin Co., Ltd. and Idemitsu Kosan, Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in his field.
Collaborations
Yoshida has collaborated with notable coworkers, including Keisuke Yamamoto and Kenji Uchida. These partnerships have fostered a creative environment that has led to the development of innovative solutions in organic electroluminescent technology.
Conclusion
Kei Yoshida's contributions to the field of organic electroluminescent elements and anticancer compounds highlight his role as a significant inventor. His work continues to pave the way for future advancements in technology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile